Table 1. Demographic and clinical characteristics of primary melanoma cases diagnosed in East Anglia during 1996–2015 (split into five– year periods).
| 1996-2000 | 2001-05 | 2006–10 | 2011-15 | 1996–2015 (total study period) |
|
|---|---|---|---|---|---|
| Total | 1516 (100.0) | 2033 (100.0) | 2,955 (100.0) | 3,386 (100.0) | 9,890 (100.0) |
| Sex | |||||
| Female | 844 (55.7) | 1,095 (53.9) | 1,465 (49.6) | 1675 (49.5) | 5,079 (51.4) |
| Male | 672 (44.3) | 938 (46.1) | 1,490 (50.4) | 1711 (50.5) | 4,811 (48.6) |
| Age group (years) | |||||
| 15–49 | 467 (30.8) | 553 (27.2) | 654 (22.1) | 662 (19.6) | 2,336 (23.6) |
| 50–54 | 172 (11.3) | 175 (8.6) | 210 (7.1) | 253 (7.5) | 810 (8.2) |
| 55–59 | 150 (9.9) | 229 (11.3) | 278 (9.4) | 264 (7.8) | 921 (9.3) |
| 60–64 | 148 (9.8) | 198 (9.7) | 391 (13.2) | 366 (10.8) | 1,103 (11.2) |
| 65–69 | 141 (9.3) | 201 (9.9) | 324 (11.0) | 449 (13.3) | 1,115 (11.3) |
| 70–74 | 152 (10.0) | 209 (10.3) | 353 (11.9) | 396 (11.7) | 1,110 (11.2) |
| 75–79 | 105 (6.9) | 211 (10.4) | 305 (10.3) | 392 (11.6) | 1,013 (10.2) |
| 80–84 | 100 (6.6) | 142 (7.0) | 233 (7.9) | 298 (8.8) | 773 (7.8) |
| 85+ | 81 (5.3) | 115 (5.7) | 207 (7.0) | 306 (9.0) | 709 (7.2) |
| Deprivation (IMD quintile) | |||||
| 1 (Least) | 404 (26.6) | 481 (23.7) | 690 (23.4) | 828 (24.5) | 2,403 (24.3) |
| 2 | 406 (26.8) | 608 (29.9) | 880 (29.8) | 1022 (30.2) | 2,916 (29.5) |
| 3 | 383 (25.3) | 532 (26.2) | 865 (29.3) | 921 (27.2) | 2,701 (27.3) |
| 4 | 236 (15.6) | 294 (14.5) | 385 (13.0) | 419 (12.4) | 1,334 (13.5) |
| 5 (Most) | 87 (5.7) | 118 (5.8) | 135 (4.6) | 196 (5.8) | 536 (5.4) |
| Stage at diagnosis | |||||
| I | 863 (56.9) | 1,192 (58.6) | 1,935 (65.5) | 2150 (63.5) | 6,140 (62.1) |
| II | 349 (23.0) | 449 (22.1) | 572 (19.4) | 652 (19.3) | 2,022 (20.4) |
| III-IV | 210 (13.9) | 287 (14.1) | 382 (12.9) | 356 (10.5) | 1,235 (12.5) |
| Missing | 94 (6.2) | 105 (5.2) | 66 (2.2) | 228 (6.7) | 493 (5.0) |